RxDoctor Payments Data

Joshua Wolfe, DPM

Foot & Ankle Surgery · Las Cruces, NMNPI 1669969390

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (33.4%), education and travel and lodging — rather than concentrated in one kind of arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.8%. Among foot & ankle surgery clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,900in general payments, 2019–2025

Across 207 payments — averaging $265.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elite Orthopedics, LLC$12K
  • Vilex LLC$11K
  • Stryker$9K
  • Flower Orthopedics Coporation$8K
  • Fusion Orthopedics USA, LLC$7K
  • Arthrex$4K
  • plus $4K from 23 others

What the payments were for

  • Consulting fees$18,36433%
  • Travel & lodging$12,95424%
  • Food & beverage$9,30617%
  • Education$14,27626%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,900 in reported general payments places this provider in the 95th percentile of 69 foot & ankle surgery providers in New Mexico.

See all foot & ankle surgery providers in New Mexico

Medicare billing

Part B allowed, 2024
$78,260
Medicare patients
196
Services billed
945

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium30$1,115
Naloxone Hcl12$752
Ibuprofen29$370
Gabapentin24$348
Meloxicam99$344
Ondansetron Hcl23$203
Cephalexin11$130
Methylprednisolone15$120
Oxycodone Hcl19$118

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Las Cruces

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →